The NM_000350.3(ABCA4):c.6416G>C variant in ABCA4 is a missense variant predicted to cause substitution of arginine by proline at amino acid 2139 (p.Arg2139Pro). The total minor allele frequency in gnomAD v4.1.0 is 0.000006195 (10/1614076 alleles), which is lower than the ClinGen ABCA4 VCEP’s threshold for PM2_Supporting (<0.0001). The computational predictor REVEL gives a score of 0.997 which is above the threshold of >0.772, evidence that predicts a damaging effect on ABCA4 function (PP3_Moderate). The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls with an OR is infinity and the CI is 2.24-infinity, which is above the ABCA4 VCEP threshold of ≥5, where the CI does not contain 1 (PS4; PMID: 35120629). This variant has been detected in at least 1 individual with ABCA4-related retinopathy who was compound heterozygous for the variant and a pathogenic variant (c.2588G>C; p.Gly863Ala) which was confirmed in trans by parental/family testing (PMID: 28559085; PM3). The variant has been reported to segregate with ABCA4-related retinopathy in the proband and 1 similarly affected relative (PP1; PMID: 25472526). Another missense variant, c.6415C>T (p.Arg2139Trp), in the same codon has been classified as pathogenic for ABCA4-related retinopathy by the ClinGen ABCA4 VCEP, and Splice AI revealed no expected effects on splicing (PM5). In summary, this variant meets the criteria to be classified as pathogenic for ABCA4-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen ABCA4 VCEP (Specification Version 1): PS4, PM3, PP1, PM2_Supporting, PP3_Moderate, PM5.